December 1, 2021

Volume XI, Number 335

Advertisement
Advertisement

December 01, 2021

Subscribe to Latest Legal News and Analysis

November 30, 2021

Subscribe to Latest Legal News and Analysis

November 29, 2021

Subscribe to Latest Legal News and Analysis

Intellectual Property, Patent, Trademark and Copyright Law News

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
11
Nov
US Copyright Office Expands Rights to Repair Software-Enabled Devices McDermott Will & Emery
11
Nov
The Plot Plot Thickens: Trade Secret, Tortious Interference, Fiduciary Duty Claims Survive Motion to Dismiss McDermott Will & Emery
11
Nov
Clearly, Prior Failures in the Art May Demonstrate Non-Obviousness McDermott Will & Emery
11
Nov
What a Deal! Car Dealers Retain Control over Their Own Data McDermott Will & Emery
9
Nov
China’s Sanya City Issues New Patent Subsidy Measures Despite CNIPA’s Push to End Them Schwegman, Lundberg & Woessner, P.A.
9
Nov
Arbitration Clause Not Binding on the United States Patent Office Proskauer Rose LLP
9
Nov
As Vehicles Become Computerized, NPE Patent Owners Are Targeting Automakers Foley & Lardner LLP
9
Nov
PTAB Finds Secondary Considerations Support a Finding of Nonobviousness of a Mechanical Invention Finnegan
8
Nov
Formulation and Administration Claims Asserted in Hatch-Waxman Pass Muster Finnegan
5
Nov
Apple Backs Down: Commits to Take Global FRAND License to Avoid Exile from UK Market Mintz
5
Nov
The Patentability of Blockchain and Cryptocurrency [VIDEO] Mintz
5
Nov
The Dangers of Informal Licensing Agreements - An Update on the Hardingham v. RP Data Case K&L Gates
5
Nov
Johnson & Johnson Medical Devices Companies Gets Patent Infringement Damages Upped 20X at China’s Supreme People’s Court Schwegman, Lundberg & Woessner, P.A.
4
Nov
A Reminder of Doctrine of Equivalents in Biotechnology: Jennewein Biotechnologie GmbH v. International Trade Commission Proskauer Rose LLP
4
Nov
USPTO Director Grants First Director Review Petition, Vacating PTAB Decision Finnegan
4
Nov
It’s Not Esoteric: Absent Ambiguity, Plain Contractual Language Governs McDermott Will & Emery
4
Nov
Standing Challenge Brews Trouble in Trademark Dispute McDermott Will & Emery
4
Nov
China’s Supreme People’s Court Rules Unintentional Short Payment of Annuity Fee Causes Termination of Patent Rights Schwegman, Lundberg & Woessner, P.A.
3
Nov
Whiskey’s Good Proofing Water, But It Doesn’t Tell You Who the Real Peaky Blinders Are Finnegan
2
Nov
Should Copyright Exceptions Apply to AI Mined Data? And Other Questions Raised Under the UKIPO Consultation on Artificial Intelligence and Copyright and Patents K&L Gates

Pages

Advertisement
Advertisement